HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2081056Generated: October 25, 2026
Ammonia → N-[(2,4-dichlorophenyl)methyl]-3-methyl-1-(1-methyl-1H-pyrazol-5-yl)-2-oxo-4-imidazolidinecarboxamide
https://huagongshe.com/reaction/2081056
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Ammonia | HCID 222 | — |
| Reactant | Potassium Phosphate, Tribasic | HCID 62657 | — |
| Reactant | (1R,2R)-N1,N1-Dimethylcyclohexane-1,2-diamine | HCID 11275066 | — |
| Reactant | 5-Iodo-1-methyl-1H-pyrazole | HCID 13334065 | — |
| Reactant | N-[(2,4-dichlorophenyl)methyl]-3-methyl-2-oxo-4-imidazolidinecarboxamide | HCID 25098283 | — |
| Catalyst | Copper(1+) iodide; Copper(I) iodide; Cuprous iodide; Cuprous iodide (CuI) | HCID 24350 | — |
| Solvent | Water | HCID 962 | — |
| Solvent | Ethyl Acetate | HCID 8857 | — |
| Solvent | 1,4-Dioxane | HCID 31275 | — |
| Product | N-[(2,4-dichlorophenyl)methyl]-3-methyl-1-(1-methyl-1H-pyrazol-5-yl)-2-oxo-4-imidazolidinecarboxamide | HCID 25095958 | 16% |
Reaction Steps
To a stirred mixture of N-[(2,4-dichlorophenyl)methyl]-3-methyl-2-oxo-4-imidazolidinecarboxamide (200 mg, 0.662 mmol) (prepared as described in Example 30), 5-iodo-1-methyl-1H-pyrazole (165 mg, 0.794 mmol) in 1,4-dioxane (20 ml) was added potassium phosphate (703 mg, 3.31 mmol), copper (I) iodide (126 mg, 0.662 mmol) and trans-N,N-dimethylcyclohexane-1,2-diamine (0.104 ml, 0.662 mmol) and the reaction mixture was heated at reflux under argon for 18 hours. After cooling to room temperature, ethyl acetate (20 ml), water (10 ml) and 0.880 ammonia solution (5 ml) were added. The organic layer was separated and the aqueous layer was extracted with ethyl acetate (2×20 ml). The organic extracts were combined, washed with citric acid solution (20 ml), water (10 ml) and brine (10 ml), dried and evaporated. The residue was purified by silica gel chromatography eluting with 0-10% methanol in dichloromethane followed by mass-directed automated HPLC to give N-[(2,4-dichlorophenyl)methyl]-3-methyl-1-(1-methyl-1H-pyrazol-5-yl)-2-oxo-4-imidazolidinecarboxamide (40 mg, 16%). LC/MS [M+H]+=382, retention time=2.12 minutes.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07932282B2 |
|---|
| Source dataset | uspto-grants-2011_04 |
|---|
| ORD ID | ord-d056dc8691224aacb77204cd0b2916db |
|---|
| Source note | uspto-grants-2011_04 |
|---|